2',3'-Dideoxyguanosine-5'-Triphosphate - (N-4002)
ddGTP
In stock
default
N-4002
Description
2',3'-Dideoxyguanosine-5'-Triphosphate (ddGTP) is a sugar modified nucleoside triphosphate, where the 2' and 3' hydroxyl groups are absent, resulting in chain termination. The inability of polymerases to extend from a dideoxy nucleotide causes the chain termination and is useful in a variety of biotechnology applications. ddGTP is used in cycle sequencing, enzyme mechanistic studies and for producing RNA and DNA sequences that cannot be extended by polymerases or joined by DNA ligases. Another notable application that utilizes a primer terminated on the 3′ end with a dideoxy modification is pyrophosphorolysis-activated polymerization (PAP). This technique is valuable for the detection of rare mutations.
"I use ddNTPs from TriLink for sequencing using DNA and RNA as templates and it always gives me good results."
Michal Legiewicz Research Scientist
Yale University
Product details
| Catalog No | N-4002 |
|---|---|
| Purity | ≥95% by AX-HPLC |
| Extinction Coefficient | 13,600 Lmol-1cm-1 at 252 nm |
| Molecular Formula | C10H16N5O12P3 (free acid) |
| Molecular Weight | 491.10 g/mole (free acid) |
| Salt Form | Li+ |
| Concentration | 100 mM |
| Buffer | H2O |
| Recommended Storage | -20°C or below |
| Other Name(s) | ddGTP |
| Application | Aptamers |
| Backbone | 5'-Triphosphate |
| Base Analog(s) | Guanosine |
| Nucleotide Category | Sugar Modified |
Technical documents
N-4002 Safety Data Sheet
Products faqs
Ask an Expert
Certificate of analysis
CoA search tool
Intellectual property
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission from TriLink No license under any patent or other intellectual property right of TriLink or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.
Related products
References
- Roettger, Michelle P.; Fiala, Kevin A.; Sompalli, Susmitha; Dong, Yuxia; Suo, Zucai . Pre-Steady-State Kinetic Studies of the Fidelity of Human DNA Polymerase â€ÂÂ
- Imbert, Isabelle; Guillemot, Jean-Claude; Bourhis, Jean-Marie; Bussetta, Cécile; Coutard, Bruno; Egloff, Marie-Pierre; Ferron, François; Gorbalenya, Alexander E.; Canard, Bruno . A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus.
- Vooradi, Venkataramana; Romano, Louis J. . Effect ofN-2-Acetylaminofluorene and 2-Aminofluorene Adducts on DNA Binding and Synthesis by Yeast DNA Polymerase
- Sahu, Sudheer; LaBean, Thomas H.; Reif, John H. . A DNA Nanotransport Device Powered by Polymerase 29
- Mizrahi, Rena A.; Schirle, Nicole T.; Beal, Peter A. . Potent and Selective Inhibition of A-to-I RNA Editing with 2′-O-Methyl/Locked Nucleic Acid-Containing Antisense Oligoribonucleotides
- Smith, Thomas M.; Lim, Siew Pheng; Yue, Kimberley; Busby, Scott A.; Arora, Rishi; Seh, Cheah Chen; Wright, S. Kirk; Nutiu, Razvan; Niyomrattanakit, Pornwaratt; Wan, Kah Fei; Beer, David; Shi, Pei-Yong; Benson, Timothy E. . Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
- Contreras-Galindo, Rafael; Dube, Derek; Fujinaga, Koh; Kaplan, Mark H.; Markovitz, David M. . Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
- Su, Kang-Yi; Lai, Hung-Ming; Goodman, Steven D.; Hu, Wei-Yao; Cheng, Wern-Cherng; Lin, Liang-In; Yang, Ya-Chien; Fang, Woei-Horng . Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay.
